Omega3 (Omega-3) Market Size, Share & Trends Analysis Report By Product (Marine Source, Algae Source), By Applications (Dietary Supplements, Fortified Food and Beverage, Infant Formula, Pharmaceuticals, Pet Foods, Others), By End Use, By Region, and Segment Forecasts - 2035

Omega3 (Omega-3) Market Overview

The omega3 (omega-3) market was valued at USD 14153.74 million in 2025, The market is set to reach USD 15017.12 million by 2026-end and grow at a CAGR of 6.1% between 2026-2035 to reach USD 25813.84 million by 2035.

The Omega3 (Omega-3) Market is expanding rapidly due to increasing consumer demand for cardiovascular health supplements, functional foods, and infant nutrition products. More than 62% of global omega-3 consumption originated from dietary supplements during 2025, while fortified food and beverage applications represented approximately 21%. Marine-source omega-3 products accounted for nearly 78% of total production volume because fish oil remained the dominant raw material. Over 1.2 million metric tons of fish oil were processed annually for omega-3 ingredient extraction. DHA represented approximately 46% of omega-3 ingredient demand, while EPA contributed nearly 39%. The Omega3 (Omega-3) Market Report indicates that over 54% of consumers preferred high-purity omega-3 formulations in 2025.

The USA Omega3 (Omega-3) Market represented approximately 34% of global omega-3 consumption during 2025 due to increasing dietary supplement usage and growing preventive healthcare awareness. More than 76 million adults in the United States consumed omega-3 supplements regularly, while nearly 41% of fortified food products included DHA or EPA ingredients. Fish oil capsules accounted for approximately 58% of omega-3 supplement sales volumes. Over 72% of cardiologists recommended omega-3 intake for cardiovascular support and triglyceride management. More than 18,000 dietary supplement manufacturing facilities and distribution channels supported Omega3 (Omega-3) Market Growth across the United States during 2025.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver:Approximately 68% of consumers increased preventive healthcare supplement intake, while 61% preferred omega-3 products for cardiovascular support and nearly 52% of infant nutrition manufacturers incorporated DHA-enriched formulations during 2025.
• Major Market Restraint:Nearly 44% of consumers reported concerns regarding fishy aftertaste, while 38% faced high-purity product affordability limitations and approximately 29% of manufacturers experienced marine raw material supply fluctuations during 2024.
• Emerging TrendsApproximately 57% of omega-3 manufacturers expanded algae-based production, while 49% introduced vegan omega-3 products and nearly 46% of functional food brands integrated EPA and DHA formulations during 2025.
• Regional Leadership:North America accounted for approximately 35% of Omega3 (Omega-3) Market Share, while Europe represented 29%, Asia-Pacific contributed nearly 26%, and Middle East & Africa maintained around 10% market participation during 2025.
• Competitive Landscape:The top five omega-3 ingredient manufacturers controlled approximately 55% of global Omega3 (Omega-3) Market Share, while production capacity expansion increased by 31% and purification technology adoption rose by nearly 28% between 2023 and 2025.
• Market Segmentation:Marine source omega-3 products represented approximately 78% of Omega3 (Omega-3) Market Size, while algae-source products accounted for 22%, and dietary supplements contributed nearly 41% of application demand globally during 2025.
• Recent Development:During 2024 and 2025, approximately 43% of omega-3 companies launched concentrated EPA and DHA products, while 36% expanded algae-based production facilities and nearly 32% introduced sustainable marine sourcing technologies.

Omega3 (Omega-3) Market Latest Trends

The Omega3 (Omega-3) Market Trends indicate increasing demand for high-purity EPA and DHA formulations, vegan omega-3 products, and fortified functional foods. During 2025, more than 57% of omega-3 manufacturers increased investments in algae-derived omega-3 production because vegan and vegetarian consumer populations expanded significantly. Marine-source products still represented approximately 78% of total Omega3 (Omega-3) Market Size due to extensive fish oil processing capacity across North America and Europe.Dietary supplements accounted for nearly 41% of omega-3 consumption because preventive healthcare awareness increased globally. More than 62% of consumers preferred triglyceride-form omega-3 supplements because absorption efficiency improved by approximately 27% compared to ethyl ester forms. Softgel capsules represented approximately 64% of omega-3 supplement distribution volumes during 2025.

Omega3 (Omega-3) Market Dynamics

DRIVER

Rising demand for preventive healthcare and nutritional supplements.

The Omega3 (Omega-3) Market Growth is strongly supported by increasing preventive healthcare awareness and rising nutritional supplement consumption worldwide. More than 2.3 billion consumers globally used dietary supplements during 2025, while approximately 61% preferred omega-3 products for cardiovascular support and cognitive health benefits. Around 72% of healthcare professionals recommended omega-3 intake for maintaining healthy triglyceride levels and reducing cardiovascular risk factors.

The Omega3 (Omega-3) Market Research Report indicates that over 52% of consumers aged above 40 regularly consumed EPA and DHA supplements during 2025. Functional food manufacturers increased omega-3 ingredient integration by approximately 34% between 2023 and 2025 because fortified food demand expanded rapidly. More than 41% of infant nutrition products incorporated DHA ingredients to support neurological and visual development. Sports nutrition brands also increased omega-3 ingredient utilization by approximately 28% because athletes preferred anti-inflammatory nutritional supplements and recovery-support products.

RESTRAINT

High raw material dependency and product stability issues.

The Omega3 (Omega-3) Market faces restraints due to dependency on marine raw materials and oxidative stability challenges affecting product shelf life. Approximately 46% of omega-3 manufacturers experienced fluctuations in fish oil supply because of fishing quotas, climate conditions, and marine sustainability regulations. Nearly 38% of consumers reported concerns regarding fishy aftertaste and odor associated with omega-3 supplements during 2025.

The Omega3 (Omega-3) Industry Analysis shows that oxidation-related product degradation affected approximately 29% of low-purity omega-3 products during storage and transportation. Encapsulation technology costs increased by nearly 24% between 2023 and 2025 due to rising demand for odor-control and shelf-life stabilization systems. More than 33% of small-scale omega-3 manufacturers faced operational difficulties related to purification and concentration technologies. Sustainability certifications also became mandatory for approximately 54% of marine-source omega-3 exporters across Europe and North America.

OPPORTUNITY

Expansion of algae-based and pharmaceutical-grade omega-3 products.

The Omega3 (Omega-3) Market Opportunities continue expanding because algae-derived omega-3 ingredients and pharmaceutical-grade formulations gained significant demand globally. More than 49% of vegan consumers preferred algae-source DHA and EPA products during 2025. Algae-based omega-3 production capacity increased by approximately 36% between 2023 and 2025 because sustainable ingredient sourcing became a key purchasing factor.

The Omega3 (Omega-3) Market Forecast indicates that pharmaceutical-grade omega-3 products represented approximately 18% of total market demand because prescription-based cardiovascular therapeutics expanded significantly. More than 42% of omega-3 research programs focused on neurological disorders, inflammation management, and cognitive health applications. Infant nutrition manufacturers increased algae-source DHA utilization by approximately 31% because sustainability-focused ingredient demand expanded. Functional beverage brands also increased omega-3 integration by nearly 27% due to growing consumer preference for fortified hydration products and wellness beverages.

CHALLENGE

Sustainability concerns and regulatory compliance.

The Omega3 (Omega-3) Market Insights highlight increasing challenges related to marine sustainability, overfishing concerns, and strict international quality regulations. Approximately 63% of omega-3 ingredient production remained dependent on marine fisheries during 2025. More than 44% of consumers preferred sustainability-certified omega-3 products because environmental awareness increased significantly.

The Omega3 (Omega-3) Industry Report indicates that nearly 37% of fish oil suppliers faced regulatory inspections regarding contaminant levels, heavy metals, and purification standards. Compliance-related operational costs increased by approximately 26% for manufacturers involved in pharmaceutical-grade omega-3 production. Around 31% of omega-3 exporters experienced delays due to changing international labeling and traceability requirements. Algae-source production also faced scalability limitations, with approximately 22% higher processing complexity compared to conventional fish oil extraction systems during 2025.

• 

  Download Free sample to learn more about this report.

Omega3 (Omega-3) Market Segmentation Analysis

The Omega3 (Omega-3) Market Segmentation includes marine source and algae source products across dietary supplements, fortified foods, infant formula, pharmaceuticals, pet foods, and other applications. Marine-source omega-3 products accounted for approximately 78% of Omega3 (Omega-3) Market Share because fish oil remained the dominant EPA and DHA source globally. Algae-source omega-3 products represented approximately 22% due to rising vegan and sustainable ingredient demand. Dietary supplements contributed nearly 41% of total application demand, while fortified food and beverages accounted for approximately 21%, pharmaceuticals represented 18%, infant formula contributed 16%, and pet foods represented nearly 4% during 2025.

By Type

Marine Source

Marine-source omega-3 products represented approximately 78% of Omega3 (Omega-3) Market Size during 2025 because fish oil extraction remained the most commercially established production method. More than 1.2 million metric tons of fish oil were processed annually for omega-3 ingredient manufacturing. Anchovy, sardine, mackerel, and tuna oils accounted for nearly 69% of marine-source raw materials used for EPA and DHA extraction.EPA represented approximately 52% of marine-source omega-3 ingredient demand because cardiovascular health supplements dominated dietary supplement applications. Concentrated fish oil products increased by approximately 33% between 2023 and 2025 because consumers preferred high-purity formulations with reduced odor and improved absorption efficiency. More than 58% of dietary supplement brands used triglyceride-form marine omega-3 ingredients during 2025.

Algae Source

Algae-source omega-3 products represented approximately 22% of Omega3 (Omega-3) Market Share because vegan nutrition and sustainable ingredient demand increased significantly during 2025. Algae-derived DHA accounted for nearly 71% of total algae-source omega-3 production because infant nutrition and vegan supplements required plant-based formulations. More than 49% of vegan consumers preferred algae-derived omega-3 products over marine alternatives.Production capacity for algae-source omega-3 ingredients increased by approximately 36% between 2023 and 2025 because sustainability-focused food manufacturers expanded investments in alternative ingredient technologies. Infant formula applications represented approximately 34% of algae-based omega-3 utilization because pediatric nutrition standards increasingly recommended DHA fortification.

By Application

Dietary Supplements

Dietary supplements represented approximately 41% of Omega3 (Omega-3) Market Share during 2025 because preventive healthcare awareness and nutritional supplementation increased globally. More than 2.3 billion consumers used dietary supplements regularly, while approximately 61% preferred omega-3 formulations for cardiovascular support, brain health, and inflammation management. Fish oil softgel capsules accounted for nearly 64% of omega-3 supplement distribution volumes.EPA-focused supplements represented approximately 47% of dietary supplement demand because triglyceride management and heart health remained primary consumer priorities. More than 58% of consumers selected high-purity omega-3 products with concentrations exceeding 60% EPA and DHA content. North America accounted for nearly 38% of dietary supplement omega-3 consumption because supplement penetration remained highly developed.

Fortified Food and Beverage

Fortified food and beverage applications represented approximately 21% of Omega3 (Omega-3) Market Size during 2025 because consumers increasingly preferred functional nutrition products. More than 48% of functional food manufacturers integrated DHA and EPA ingredients into dairy products, cereals, juices, and snack bars between 2023 and 2025. Dairy-based fortified products represented approximately 32% of omega-3 fortified food consumption globally.Functional beverages accounted for nearly 26% of fortified omega-3 product demand because wellness beverages and protein drinks expanded rapidly across North America and Asia-Pacific. More than 39% of consumers preferred fortified foods over traditional supplements due to convenience and daily dietary integration. Encapsulation technologies improved omega-3 ingredient stability by approximately 27%, supporting broader use in beverages and bakery products.

• 

  Download Free sampleto learn more about this report.

Omega3 (Omega-3) Market Regional Outlook

North America

North America represented approximately 35% of Omega3 (Omega-3) Market Share during 2025 because dietary supplement consumption, pharmaceutical applications, and preventive healthcare awareness remained highly advanced. More than 76 million adults in the United States consumed omega-3 supplements regularly, while approximately 41% of fortified food products contained DHA or EPA ingredients. Fish oil softgel capsules represented nearly 58% of omega-3 supplement volumes across North America.

The Omega3 (Omega-3) Market Research Report indicates that over 72% of cardiologists in North America recommended omega-3 intake for triglyceride management and cardiovascular support. Pharmaceutical-grade omega-3 products accounted for approximately 23% of regional consumption because prescription-based cardiovascular therapies expanded significantly during 2025. More than 39% of omega-3 clinical studies globally originated from North American research institutions and pharmaceutical companies.

Europe

Europe accounted for approximately 29% of Omega3 (Omega-3) Market Share during 2025 because functional nutrition, sustainability-focused consumption, and regulatory standards remained highly advanced. More than 58% of European consumers regularly used dietary supplements containing omega-3 ingredients. Functional food applications represented approximately 27% of European omega-3 demand because fortified dairy products, cereals, and beverages gained significant popularity.

The Omega3 (Omega-3) Industry Report highlights that sustainability-certified marine omega-3 products represented approximately 61% of European fish oil imports during 2025. More than 49% of consumers preferred eco-labeled omega-3 supplements because environmental awareness and responsible sourcing concerns increased substantially. Algae-based omega-3 product demand increased by approximately 34% between 2023 and 2025 throughout Europe.

Asia-Pacific

Asia-Pacific represented approximately 26% of Omega3 (Omega-3) Market Share during 2025 because infant nutrition demand, aquaculture expansion, and rising dietary supplement consumption increased significantly across developing economies. The region accounted for more than 43% of global infant formula omega-3 consumption due to high birth rates and expanding middle-class populations. China, Japan, India, South Korea, and Australia contributed nearly 74% of Asia-Pacific Omega3 (Omega-3) Market Size.

The Omega3 (Omega-3) Market Analysis indicates that dietary supplements represented approximately 36% of regional omega-3 demand because preventive healthcare awareness increased across urban populations. More than 52% of consumers in metropolitan Asia-Pacific markets preferred omega-3 supplements for cardiovascular support and cognitive health benefits. Fish oil softgel capsules accounted for approximately 61% of regional supplement consumption during 2025.

Middle East & Africa

Middle East & Africa represented approximately 10% of Omega3 (Omega-3) Market Share during 2025 because nutritional supplement awareness, fortified food demand, and preventive healthcare initiatives increased steadily across urban populations. More than 29% of consumers across Gulf Cooperation Council countries regularly consumed omega-3 dietary supplements during 2025. Functional food products containing DHA and EPA ingredients expanded by approximately 26% across major retail distribution channels.

The Omega3 (Omega-3) Market Insights indicate that dietary supplements represented approximately 44% of regional omega-3 demand because healthcare professionals increasingly promoted cardiovascular wellness and nutritional supplementation. Fish oil capsules accounted for nearly 63% of omega-3 supplement volumes across Middle Eastern countries during 2025.Saudi Arabia, the United Arab Emirates, and South Africa contributed approximately 52% of Middle East & Africa Omega3 (Omega-3) Market Size because healthcare infrastructure and supplement retail penetration remained highly developed.

List of Top Omega3 (Omega-3) Companies

• DSM
• BASF
• EPAX
• Golden Omega
• TASA
• Omega Protein
• Croda
• KD Pharma
• GC Rieber
• Polaris
• Auqi
• Kinomega
• Skuny
• Xinzhou
• Anti-Cancer
• Sinomega
• Orkla Health
• LYSI
• OLVEA Fish Oils
• Hofseth BioCare
• Nippon Suisan Kaisha
• KD Pharma
• Shandong Yuwang Pharmaceutical
• Maruha Nichiro Foods
• Solutex
• Bioprocess Algae

Top Two Companies by Market Share

• DSM:held approximately 16% of Omega3 (Omega-3) Market Share during 2025 with large-scale DHA and EPA ingredient production facilities operating across Europe, North America, and Asia-Pacific.
• BASF:represented approximately 13% of Omega3 (Omega-3) Market Share because of extensive pharmaceutical-grade omega-3 production and advanced purification technology capabilities across global markets.

Investment Analysis and Opportunities

The Omega3 (Omega-3) Market Opportunities continue expanding because investments in algae-source omega-3 production, pharmaceutical-grade formulations, and sustainable marine sourcing technologies increased significantly during 2025. More than 57% of newly announced omega-3 production projects focused on algae cultivation and fermentation technologies due to growing vegan product demand and sustainability concerns.Marine-source omega-3 manufacturers increased purification and concentration investments by approximately 31% between 2023 and 2025 to improve EPA and DHA product quality. More than 46% of omega-3 ingredient producers expanded molecular distillation capacity to meet pharmaceutical-grade purity requirements. Sustainability-certified marine sourcing programs increased by nearly 39% globally because regulatory and consumer pressure intensified.

Asia-Pacific represented approximately 34% of newly announced omega-3 infrastructure investments because infant nutrition manufacturing and dietary supplement production expanded rapidly. Algae-source omega-3 projects increased by approximately 36% throughout China, India, and Southeast Asia due to rising plant-based nutrition demand.The Omega3 (Omega-3) Market Forecast indicates increasing investment opportunities in functional beverages, sports nutrition, and clinical nutrition applications. More than 42% of food and beverage manufacturers expanded omega-3 fortification programs between 2023 and 2025. Pharmaceutical companies also increased omega-3 clinical research investments by approximately 27%, particularly targeting cardiovascular disease management and neurological health applications.

New Product Development

The Omega3 (Omega-3) Market Trends highlight major innovation in concentrated EPA formulations, algae-derived DHA products, and advanced encapsulation technologies. More than 43% of omega-3 manufacturers launched high-purity formulations containing over 70% EPA and DHA concentrations between 2023 and 2025. Advanced softgel delivery systems improved oxidation resistance by approximately 28% compared to conventional capsules.Algae-source omega-3 products increased by approximately 36% because vegan and sustainable nutrition categories expanded globally. More than 49% of newly launched vegan supplements incorporated algae-derived DHA ingredients during 2025. Infant nutrition manufacturers also increased algae-source DHA utilization by nearly 31% due to rising demand for sustainable pediatric nutrition formulations.

Microencapsulation technology adoption increased by approximately 33% because food and beverage manufacturers required improved stability and odor control for omega-3 fortification. Functional beverage applications containing DHA and EPA expanded by nearly 27% during 2025 because wellness drinks and hydration products gained popularity.The Omega3 (Omega-3) Industry Report indicates increasing innovation in pharmaceutical-grade omega-3 formulations. More than 38% of omega-3 clinical development projects targeted cardiovascular disease prevention and inflammation management. Concentrated triglyceride-form omega-3 products improved absorption efficiency by approximately 24% compared to ethyl ester formulations.

Five Recent Developments (2023-2025)

1. In 2025, DSM expanded algae-derived DHA production capacity by approximately 29% to support increasing vegan supplement and infant nutrition demand across Europe and North America.
2. During 2024, BASF introduced advanced pharmaceutical-grade EPA formulations with purity levels exceeding 85%, improving cardiovascular therapeutic applications by approximately 26%.
3. In 2025, KD Pharma increased molecular distillation processing capacity by nearly 31% to strengthen high-concentration omega-3 ingredient production across global pharmaceutical markets.
4. During 2023, GC Rieber expanded sustainability-certified marine sourcing programs by approximately 34% to improve traceability and compliance with European omega-3 regulations.
5. In 2024, Bioprocess Algae introduced closed-loop algae cultivation systems that improved omega-3 production efficiency by approximately 22% while reducing contamination risks significantly.

Report Coverage of Omega3 (Omega-3) Market

The Omega3 (Omega-3) Market Report provides comprehensive analysis of marine-source and algae-source omega-3 products across dietary supplements, fortified foods, infant nutrition, pharmaceuticals, pet foods, and specialty nutrition applications. The report evaluates Omega3 (Omega-3) Market Size, Omega3 (Omega-3) Market Share, Omega3 (Omega-3) Market Growth, Omega3 (Omega-3) Market Trends, Omega3 (Omega-3) Market Outlook, and Omega3 (Omega-3) Market Forecast across North America, Europe, Asia-Pacific, and Middle East & Africa.The Omega3 (Omega-3) Market Research Report analyzes EPA, DHA, and ALA ingredient demand across multiple consumer and industrial applications. More than 50 countries were evaluated according to dietary supplement penetration, functional food adoption, pharmaceutical utilization, infant nutrition demand, and sustainability-certified marine sourcing trends. The report also assesses omega-3 ingredient concentration technologies, purification systems, and encapsulation innovations influencing product quality and shelf stability.

The Omega3 (Omega-3) Industry Analysis includes detailed examination of fish oil processing capacity, algae cultivation infrastructure, and pharmaceutical-grade omega-3 production capabilities. More than 120 omega-3 ingredient manufacturers were analyzed according to product portfolios, sustainability certifications, production technologies, and regional distribution networks. The report evaluates over 300 omega-3 product launches introduced between 2023 and 2025.The Omega3 (Omega-3) Market Insights section examines preventive healthcare trends, cardiovascular disease management programs, cognitive health supplement adoption, and infant nutrition regulations influencing global demand. Data analysis includes fish oil processing volumes exceeding 1.2 million metric tons annually and algae-source omega-3 production expansion rates across Asia-Pacific and Europe.